Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
205.4 SEK | +0.39% |
|
0.00% | +61.13% |
18/06 | Calliditas Therapeutics Gets US Patent for Cancer Treatment Candidate | MT |
18/06 | Calliditas Therapeutics Secures US Patent for Cancer Treatment Inhibitor | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+61.13% | 1.05B | |
+15.09% | 76.49B | |
+13.50% | 8.99B | |
-22.91% | 4.39B | |
+33.84% | 4.19B | |
+10.76% | 4.13B | |
+8.41% | 2.16B | |
-30.28% | 2.07B | |
+8.58% | 1.96B | |
-44.99% | 1.72B |
- Stock Market
- Equities
- CALTX Stock
- News Calliditas Therapeutics AB
- Calliditas Partner Secures European Panel Backing for Rare Kidney Disease Treatment